Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results
January 09, 2022 14:00 ET
|
Emergent BioSolutions
Expects a re-baseline of operations with stable revenue contributions from core products and services business in 2022, guiding to total revenues of $1.45 billion at the midpoint and Adjusted EBITDA...
Emergent BioSolutions to Participate in Investor Conferences
January 03, 2022 06:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...
Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results
January 10, 2021 14:00 ET
|
Emergent BioSolutions
Expects continued strong financial and operating momentum in 2021, forecasting total revenues of $2 billion at the midpoint and Adjusted EBITDA of $780 million at the midpoint, both increases...
Emergent BioSolutions to Participate in Investor Conferences
January 04, 2021 06:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...
Emergent BioSolutions Announces Preliminary 2019 Financial Results and Provides 2020 Financial Forecast
January 13, 2020 06:30 ET
|
Emergent BioSolutions
Full year 2019 preliminary revenues and adjusted profitability metrics in line with prior guidanceFull year 2020 forecast reflects continued growth of core business as well as investments in key...
Emergent BioSolutions to Participate in Investor Conferences
January 06, 2020 06:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...
Emergent BioSolutions Announces Preliminary 2018 Financial Results and Provides 2019 Financial Forecast
January 07, 2019 06:30 ET
|
Emergent BioSolutions
Full year 2018 preliminary performance in line with recently revised guidanceFull year 2019 forecast reflects continued growth of organic business and anticipated positive impact of recent...
Emergent BioSolutions Announces Preliminary 2016 Financial Results and Provides 2017 Financial Outlook
January 09, 2017 07:00 ET
|
Emergent BioSolutions Inc.
GAITHERSBURG, Md., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced preliminary unaudited 2016 financial results and guidance for 2017. Daniel J. Abdun-Nabi,...